Amrutanjan Health Care · NSE: AMRUTANJAN · BSE: 590006
Q4 FY25 results · Jan–Mar 2025
Amrutanjan Health Care reported revenue from operations of ₹135.41 crore (up 6.6% from Q4 FY24) and net profit of ₹15.18 crore (up 11.1% from Q4 FY24) for Q4 FY25 (Jan–Mar 2025), on a standalone basis.
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 135.41 | 127.06 | +6.6% | 122.75 | +10.3% |
| Other income | 4.82 | 5.54 | −13.1% | 4.36 | +10.5% |
| Total income | 140.23 | 132.61 | +5.8% | 127.11 | +10.3% |
| Profit before tax | 20.86 | 19.60 | +6.4% | 25.99 | −19.8% |
| Net profit for the period | 15.18 | 13.66 | +11.1% | 19.25 | −21.1% |
| EPS, basic (₹) | 5.25 | 4.72 | +11.2% | 6.66 | −21.2% |
| Net margin (%) | 11.2 | 10.7 | 15.7 |
Standalone
- Filed with BSE
- 23 Jun 2025, 17:37 IST
- Board meeting
- 15 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE